The Future of Injectable Glutathione and Antioxidant Optimization in Longevity Medicine Emerging Research and Clinical Applications The scientific understanding of glutathione's roles in health and disease continues to evolve, with ongoing research exploring therapeutic applications beyond general antioxidant support
KRASmulti inhibitor BI 3706674, an orally bioavailable, direct inhibitor of diverse oncogenic KRAS variants drives tumor regression in KRASG12V-driven preclinical models
[110] reported a peptide library comprising a series of functionalized dialkynyl linkers equipped with double CuAAC staple
NAD precursors like NMN or NR are also being studied, but long-term human data is still developing
In cancer, the same H 2 O 2 signals that sustain growth and EMT coexist with antioxidant rewiring, creating a therapeutic window where node- and compartment-specific interventions (NOX/NOS modulation, mitochondrial quality control, iron/ferroptosis management, calibrated RSS support) outperform blanket scavenging (Lankheet et al